Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07611032
NA

A Single-Arm Exploratory Study of NatureU Histra Disslove on Chronic Urticaria Symptoms

Sponsor: OmniSolutions Laboratory Holdings Limited

View on ClinicalTrials.gov

Summary

This was a single-center, open-label, single-arm, exploratory self-controlled study evaluating NatureU Histra Disslove in adults with chronic urticaria symptoms. Twenty-four participants were screened, 19 participants were enrolled, and 19 participants completed the study and were included in the effectiveness analysis. Participants took one tablet of the study product orally once daily, 20 minutes before a main meal, for 28 consecutive days. Urticaria Control Test, Urticaria Activity Score 7, and Dermatology Life Quality Index assessments were performed at baseline, Day 14, and Day 28. Safety was monitored during the study.

Official title: A Single-Center, Open-Label, Single-Arm Exploratory Self-Controlled Study of NatureU Histra Disslove on Urticaria Control, Urticaria Activity, and Dermatology Quality of Life in Adults With Chronic Urticaria Symptoms

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

19

Start Date

2024-10-04

Completion Date

2024-11-01

Last Updated

2026-05-28

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

NatureU Histra Disslove

NatureU Histra Disslove is a food product containing active diamine oxidase (DAO). Participants took one tablet orally once daily, 20 minutes before a main meal, preferably dinner, for 28 consecutive days.

Locations (1)

Dao County People's Hospital

Yongzhou, Hunan, China